Association of khat chewing with increased risk of stroke and death in patients presenting with acute coronary syndrome

Mayo Clinic Proceedings

Volumn 85, Issue 11, 2010, Pages 974-980

  Ali, Waleed M ^a   Zubaid, Mohammad ^b   Al Motarreb, Ahmed ^c   Singh, Rajivir ^e   Al Shereiqi, Sulaiman Z ^d   Shehab, Abdulah ^f   Rashed, Wafa ^g   Al Sagheer, Norah Q ^h   Saleh, Abdo H ⁱ   Al Suwaidi, Jassim ^a  

^a HAMAD GENERAL HOSPITAL   (Qatar)

^b KUWAIT UNIVERSITY   (Kuwait)

^c SANA A UNIVERSITY   (Yemen)

^d MINISTRY OF HEALTH   (Oman)

^e HAMAD MEDICAL CORPORATION   (Qatar)

^f UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^g MUBARAK AL KABEER HOSPITAL   (Kuwait)

^h Al Thawrah Hospital   (Yemen)

ⁱ Al Jomhori Hospital   (Yemen)

Author keywords

[No Author keywords available]

Indexed keywords

CATHA EDULIS EXTRACT;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CATHA EDULIS; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY REPERFUSION; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASTICATION; MORTALITY; MULTICENTER STUDY; OBESITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE;

EID: 78149338621     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0398     Document Type: Article

References (49)

1. Kalix P. The pharmacology of khat. Gen Pharmacol. 1984;15:179-187.
2. Kennedy JG. The Flower of Paradise: The Institutionalized Use of the Drug Qat in North Yemen. Dordrecht, The Netherlands: Springer;1987:60-107.
3. Getahun A, Krikorian AD. Chat: coffee's rival from Harar, Ethiopia: I. botany, cultivation and use. Econ Bot. 1973;27:353-377.
4. Brenneisen R, Fisch HU, Koelbing U, Geisshusler S, Kalix P. Amphetamine-like effects in humans of the khat alkaloid cathinone. Br J Clin Pharmacol. 1990;30:825-828.
5. Kalix P. Cathinone a natural amphetamine. Pharmacol Toxicol. 1992;70(2):77-86.
6. Cox G, Rampes H. Adverse effects of khat: a review. Adv Psychiatr Treat. 2003;9:456-463.
7. Balint EE, Falkay G, Balint GA. Khat - a controversial plant. Wien Klin Wochenschr. 2009;121:604-614.
8. Kalix P. Catha edulis, a plant that has amphetamine effects. Pharm World Sci. 1996;18:69-73. (Pubitemid 26155493)
9. Intitute for the Study of Drug Dependence. Druglink Factsheet No. 9. Khat (Qat, Chat). London, England: Institute for the Study of Drug Dependence; 1994.
10. Browne DL. Qat use in New York City. NIDA Res Monogr. 1990;105:464-465.
11. Khat (Catha edulis). Intelligence Bulletin 2003-L0424-002. National Drug Intelligence Center Web site. Published May 2003. http://www.justice. gov/ndic/pubs3/3920/index.htm. Accessed August 5, 2010.
12. Anderson D, Beckerleg S, Hailu D, Klein A. The Khat Controversy: Stimulating the Debate on Drugs. Oxford, UK: Berg; 2007:62-65.
13. El-Menyar A, Zubaid M, Sulaiman K, Al Thani H, Singh R, Al Suwaidi J. In-hospital major outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a registry of 8,176 patients. Mayo Clin Proc. 2010;85(4):332-340.
14. El-Menyar A, Zuabid M, Rashed W, et al. Comparison of men and women with acute coronary syndrome in six Middle Eastern countries. Am J Cardiol. 2009;104(8):1018-1022.
15. Al Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with cute coronary syndrome. Circulation. 2002;106:974-980.
16. Cornnor J, Makonnen E, Rostom A. Comparison of analgesic effects of Khat (Catha edulis Forsk) extract, D-amphetamine and ibuprofen in mice. J Pharm Pharmacol. 2000;52(1):107-110.
17. Al-Motarreb A, Briancon S, Al-Jaber N, et al. Khat-chewing is a risk factor for acute myocardial infarction: a case-control study. Br J Clin Pharmacol. 2005;59:574-581.
18. Al-Motarreb A, Al-Kebsi M, Al-Adhi B, Broadley KJ. Khat chewing and acute myocardial infarction. Heart. 2002;87(3):279-280.
19. Alkadi HO, Noman MA, Al-Thobhani AK, Al-Mekhlafi FS, Raja'a YA. Clinical and experimental evaluation of the effect of Khat induced myocardial infarction. Saudi Med J. 2002;23:1195-1198.
20. Alem A, Kebede D, Kullgren G. The prevalence and socio-demographic correlates of khat chewing in Butajira, Ethiopia.. Acta Psychiatr Scand Suppl. 1999;397:84-91. (Pubitemid 29372554)
21. Griffiths R. Qat use in London: a study of qat use among a sample of Somalis living in London. London, England: Home Office, Central Drugs Prevention Unit. 1998. Drugs Prevention Initiative Paper No. 26.
22. Bhui K, Abdi A, Abdi M, et al. Traumatic events, migration characteristics and psychiatric symptoms among Somali refugees-preliminary communication. Soc Psychiatry Psychiatr Epidemiol. 2003;38(1):35-43.
23. Griffiths P, Gossop M, Wickenden S, Dunworth J, Harris K, Lloyd C. A transcultural pattern of drug use: qat (khat) in the UK. Br J Psychiatry. 1997;170:281-284.
24. Patel SL. Attitudes to khat use within the Somali community in England. Drugs Educ Prev Policy. 2008;15(1):37-53.
25. Tesfaye F, Byass P, Wall S, Berhane Y, Bonita R. Association of smoking and khat (Catha edulis Forsk) use with high blood pressure among adults in Addis Ababa, Ethiopia 2006. Prev Chronic Dis. 2008;5(3):A89.
26. Hassan NA, Gunaid AA, Abdo-Rabbo AA, et al. The effect of Qat chewing on blood pressure and heart rate in healthy volunteers. Trop Doct. 2000;30:107-108.
27. Toennes SW, Harder S, Schramm M, Niess C, Kauert GF. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. Br J Clin Pharmacol. 2003;56(1):125-130.
28. Hassan NA, Gunaid AA, Khally FM, Murray-Lyon IM. Khat chewing and arterial blood pressure: a randomized controlled clinical trial of alpha-1 and selective beta-1 adrenoreceptor blockade. Saudi Med J. 2005;26:537-541.
29. Gugelmann R, von Allmen M, Breinneisen R, Portzig H. Quantitative differences in the pharmacological effect of (+) and (-)-cathinone. Experientia. 1985;41:1568-1571.
30. Saha S, Dollery C. Severe ischemic cardiomyopathy associated with khat chewing. J R Soc Med. 2006;99:316-318.
31. Bawazeer A, Hattab A, Morales E. First cigarette smoking experience among secondary-school students in Aden, Republic of Yemen. East Mediterr Health J. 1999;5:440-449.
32. Haft JI, Kranz PD, Albert FJ, Fani K. Intravascular platelet aggregation in the heart induced by norepinephrine: microscopic studies. Circulation. 1972;46:698-708.
33. Al-Motarreb A, Broadley KJ. Coronary and aortic vasoconstriction by cathinone, the active constituent of khat. Auton Autacoid Pharmacol. 2003;23(5-6):319-326.
34. Baker KE, Herbert AA, Broadley KJ. Vasoconstriction of porcine left anterior descending coronary artery by ecstasy and cathinone is not an indirect sympathomimetic effect.. Vascul Pharmacol. 2007;47(1):10-17.
35. Ragland AS, Ismail Y, Arsura EL. Myocardial infarction after amphetamine use. Am Heart J. 1993;125:247-249.
36. Packe GE, Garton MJ, Jennings K. Acute myocardial infarction caused by intravenous amphetamine abuse. Br Heart J. 1990;64:23-24.
37. Wijetunga M, Bhan R, Lindsay J, Karch S. Acute coronary syndrome and crystal methamphetamine use: a case series. Hawaii Med J. 2004;63:8-13, 25.
38. Turnipseed SD, Richards JR, Kirk JD, Diercks DB, Amsterdam EA. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med. 2003;24:369-373.
39. Bashour TT. Acute myocardial infarction resulting from amphetamine abuse: spasm-thrombus interplay? Am Heart J. 1994;128:1237-1239.
40. Graziani M, Milella MS, Nencini P. Khat chewing from the pharmacological point of view: an update. Subst Use Misuse. 2008;43:762-783.
41. Yeo KK, Wijetunga M, Ito H, et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med. 2007;120:165-171.
42. Robinson M, Turnipseed S, Glatter K. Methamphetamine-associated cardiomyopathy: a previously unrecognized cause of heart failure [abstract]. Presented at: American Heart Association Annual Scientific Sessions. New Orleans, LA: 2004.
43. Maeno Y, Iwasa M, Inoue H, et al. Direct effects of methamphetamineon hypertrophy and microtubules in cultured adult rat ventricular myocytes. Forensic Sci Int. 2000;113:239-243.
44. He SY, Matoba R, Fujitani N, Koyama H, Matoba R, Nagao M. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol. 1996;17(2):155-162.
45. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med. 1990;112:897-903.
46. Vanwalleghem IE, Vanwalleghem PW, De Bleecker JL. Khat chewing can cause stroke. Cerebrovasc Dis. 2006;22:198-200.
47. Mujlli HM, Bo X, Zhang L. The effect of Khat (Catha edulis) on acute cerebral infarction [abstract]. Neurosciences. 2005;10:219-222.
48. Bruno A. Cerebrovascular complications of alcohol and sympathomimetic drug abuse. Curr Neurol Neurosci Rep. 2003;3:40-45.
49. Miranda J, O'Neill D. Stroke associated with amphetamine use. Ir Med J. 2002;95:281-282.